Standard BioTools completes $350 million SomaLogic sale to Illumina
Tweet Send to a Friend
Standard BioTools Inc. (NASDAQ: LAB) completed the sale of SomaLogic to Illumina Inc. (NASDAQ: ILMN) for $350 million in upfront ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
